Q: Hello Peter,
Since the article in the Globe about Nuvo Research, the stock has surged. Is there other news you are aware of that is moving the stock higher? Also, Concordia's numbers were excellent even though they missed the estimate. Is this the reason why the stock is flat since the earnings and in general when companies continue to increase their revenues and Earnings but miss estimates, is this a bad sign for a stock as i thought the analyst estimates was just one factor in buying and selling not the complete reason for owning or selling the stock. Thanks for your advice.
Since the article in the Globe about Nuvo Research, the stock has surged. Is there other news you are aware of that is moving the stock higher? Also, Concordia's numbers were excellent even though they missed the estimate. Is this the reason why the stock is flat since the earnings and in general when companies continue to increase their revenues and Earnings but miss estimates, is this a bad sign for a stock as i thought the analyst estimates was just one factor in buying and selling not the complete reason for owning or selling the stock. Thanks for your advice.